Amgen signs $800 million deal with IBM
This article was originally published in Scrip
Amgenhas signed a five-year $500 million service agreement withIBM. IBMwill supply the biotech company with information systems infrastructure services, including electronic messaging systems, networks, helpdesk support for end users, physical information technology support, server hosting applications and information systems hardware. It will also develop methods, processes and technologies being used to provide information systems infrastructure services. Amgen may choose to extend the deal for a further three years, bringing the total amount payable to IBM to $800 million.